SIYOMICRO today announced that it has raised RMB 100 million-level financing. The round was led by a leading strategic industrial investor, with participation from Goldport Capital and Longgang Guiding Fund.
The proceeds from this financing will be primarily used to build SIYOMICRO’s synthetic biology platform, further accelerate the development of multi-host cell systems and product commercialization, and advance the company’s strategic deployment in large-scale biomanufacturing products.
CEC Capital acted as the sole financial advisor to SIYOMICRO in this transaction.
Bonnie Guo
Tel:+86 (10) 8519 2080
Fax:+86 (10) 8519 2078